2 articles
- 2d agoYahooEarliestCancer Vaccines Are Advancing. Can Regulators Keep Up?
- 2d agoReasonPickupCancer Vaccines Are Advancing. Can Regulators Keep Up?
Why it’s here: Covers cancer vaccine advances and the FDA's regulatory challenges for personalized biotech therapies, plus HHS cuts to mRNA investments, which fall squarely in biotechnology federal policy, though the piece argues for ending FDA's drug-approval monopoly from a libertarian perspective.
Trace across the board